COMMUNIQUÉS West-GlobeNewswire
-
Nature Medicine Reports Elimination of Large Tumors in Mice by Messenger RNA-Encoded Bispecific Antibodies
12/06/2017 - 17:01 -
Prothena Announces Appointment of Wagner Zago, PhD as Chief Scientific Officer
12/06/2017 - 15:00 -
ProLynx announces PLX039, a hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonist
12/06/2017 - 15:00 -
Solon Eiendom ASA : Bionor Pharma winding down operations
12/06/2017 - 12:52 -
Saniona AB: Saniona publishes prospectus for listing of shares on Nasdaq Stockholm
12/06/2017 - 12:15 -
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
12/06/2017 - 11:19 -
DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company
12/06/2017 - 11:19 -
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
12/06/2017 - 09:00 -
Zealand to regain control of elsiglutide
12/06/2017 - 08:48 -
Herantis Pharma's clinical study with CDNF in Parkinson's disease authorized in Finland, company expands on development plan
12/06/2017 - 08:00 -
Immunicum AB (publ) Announces Approval of the International Nonproprietary Name (INN) ilixadencel for INTUVAX®
12/06/2017 - 08:00 -
Basilea announces clinical study agreement with Adult Brain Tumor Consortium to explore BAL101553 in newly diagnosed glioblastoma
12/06/2017 - 07:15 -
TiGenix announces final equity payment for cardiac platform acquisition
12/06/2017 - 07:00 -
TiGenix annonce le paiement final en actions pour l'acquisition de sa plateforme cardiaque
12/06/2017 - 07:00 -
Probiodrug announces encouraging results of the Phase 2a SAPHIR Study
11/06/2017 - 21:06 -
Sanofi and Regeneron Announce Positive Results from First Dedicated Studies Evaluating Praluent® (alirocumab) in Individuals with Diabetes and Hypercholesterolemia
11/06/2017 - 17:01 -
Sanofi et Regeneron annoncent les résultats positifs des premières études consacrées à l'évaluation de Praluent® (alirocumab) chez des personnes présentant un diabète et une hypercholestérolémie
11/06/2017 - 17:01 -
New analysis shows Soliqua® 100/33 lowered HbA1c by more than 2% in patients with screening levels greater than 9%
10/06/2017 - 19:14 -
Dasiglucagon (pINN) presentation at the 77th Scientific Sessions of the American Diabetes Association (ADA) indicate use for treatment of severe hypoglycemia
10/06/2017 - 19:08
Pages